Maria B Schiavone1, Lea Moukarzel1, Kam Leong1, Qin C Zhou2, Anoushka M Afonso3, Alexia Iasonos2, Kara Long Roche4, Mario M Leitao4, Dennis S Chi4, Nadeem R Abu-Rustum4, Oliver Zivanovic5. 1. Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States. 2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States. 3. Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States. 4. Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of OB/GYN, Weill Cornell Medical College, New York, NY, United States. 5. Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of OB/GYN, Weill Cornell Medical College, New York, NY, United States. Electronic address: zivanovo@mskcc.org.
Abstract
OBJECTIVE: Surgical site infections (SSIs) can lead to substantial morbidity, prolonged hospitalization, increased costs, and death in patients undergoing colorectal procedures. We sought to investigate the effect of using an SSI reduction bundle on the rate of SSIs in gynecologic cancer patients undergoing colon surgery. METHODS: We identified all gynecologic cancer patients who underwent colon resection at our institution from 2014 to 2016, during which time a service-wide SSI reduction bundle was introduced. The intervention included preoperative oral antibiotics with optional mechanical bowel preparation, skin preparation with antibacterial solution, and the use of a separate surgical closing tray. SSI rates were assessed within 30days post-surgery. RESULTS: Of 233 identified patients, 115 had undergone colon surgery prior to (PRE) and 118 after (POST) the implementation of the intervention. A low anterior resection was the most common colon surgery in both cohorts. The incidence of SSI within 30days of surgery was 43/115 (37%) in the PRE and 14/118 (12%) in the POST cohorts (p≤0.001). Wound dehiscence was noted in 30/115 (26%) and 2/118 (2%) patients, respectively (p≤0.001). In patients whose operation took longer than 360min, 30-day SSI rates were 37% (28/76) and 12% (8/67), respectively (p≤0.001). In patients with an estimated blood loss >500cm3, SSI rates were 44% (27/62) and 15% (10/67), respectively (p≤0.001). CONCLUSIONS: The implementation of an SSI reduction bundle was associated with a significant reduction in 30-day SSIs in these patients. The intervention remained effective in patients undergoing longer operations and in those with increased blood loss.
OBJECTIVE: Surgical site infections (SSIs) can lead to substantial morbidity, prolonged hospitalization, increased costs, and death in patients undergoing colorectal procedures. We sought to investigate the effect of using an SSI reduction bundle on the rate of SSIs in gynecologic cancerpatients undergoing colon surgery. METHODS: We identified all gynecologic cancerpatients who underwent colon resection at our institution from 2014 to 2016, during which time a service-wide SSI reduction bundle was introduced. The intervention included preoperative oral antibiotics with optional mechanical bowel preparation, skin preparation with antibacterial solution, and the use of a separate surgical closing tray. SSI rates were assessed within 30days post-surgery. RESULTS: Of 233 identified patients, 115 had undergone colon surgery prior to (PRE) and 118 after (POST) the implementation of the intervention. A low anterior resection was the most common colon surgery in both cohorts. The incidence of SSI within 30days of surgery was 43/115 (37%) in the PRE and 14/118 (12%) in the POST cohorts (p≤0.001). Wound dehiscence was noted in 30/115 (26%) and 2/118 (2%) patients, respectively (p≤0.001). In patients whose operation took longer than 360min, 30-day SSI rates were 37% (28/76) and 12% (8/67), respectively (p≤0.001). In patients with an estimated blood loss >500cm3, SSI rates were 44% (27/62) and 15% (10/67), respectively (p≤0.001). CONCLUSIONS: The implementation of an SSI reduction bundle was associated with a significant reduction in 30-day SSIs in these patients. The intervention remained effective in patients undergoing longer operations and in those with increased blood loss.
Authors: Kristen A Ban; Joseph P Minei; Christine Laronga; Brian G Harbrecht; Eric H Jensen; Donald E Fry; Kamal M F Itani; E Patchen Dellinger; Clifford Y Ko; Therese M Duane Journal: J Am Coll Surg Date: 2016-11-30 Impact factor: 6.113
Authors: Benedetta Allegranzi; Bassim Zayed; Peter Bischoff; N Zeynep Kubilay; Stijn de Jonge; Fleur de Vries; Stacey M Gomes; Sarah Gans; Elon D Wallert; Xiuwen Wu; Mohamed Abbas; Marja A Boermeester; E Patchen Dellinger; Matthias Egger; Petra Gastmeier; Xavier Guirao; Jianan Ren; Didier Pittet; Joseph S Solomkin Journal: Lancet Infect Dis Date: 2016-11-02 Impact factor: 25.071
Authors: Megan P Johnson; Sharon J Kim; Carrie L Langstraat; Sneha Jain; Elizabeth B Habermann; Jean E Wentink; Pamela L Grubbs; Sharon A Nehring; Amy L Weaver; Michaela E McGree; Robert R Cima; Sean C Dowdy; Jamie N Bakkum-Gamez Journal: Obstet Gynecol Date: 2016-06 Impact factor: 7.661
Authors: Martin Hübner; Michele Diana; Giorgio Zanetti; Marie-Christine Eisenring; Nicolas Demartines; Nicolas Troillet Journal: Arch Surg Date: 2011-07-18
Authors: Robert L Smith; Jamie K Bohl; Shannon T McElearney; Charles M Friel; Margaret M Barclay; Robert G Sawyer; Eugene F Foley Journal: Ann Surg Date: 2004-05 Impact factor: 12.969
Authors: Shitanshu Uppal; John Harris; Ahmed Al-Niaimi; Carolyn W Swenson; Mark D Pearlman; R Kevin Reynolds; Neil Kamdar; Ali Bazzi; Darrell A Campbell; Daniel M Morgan Journal: Obstet Gynecol Date: 2016-02 Impact factor: 7.661
Authors: Aurora Pop-Vicas; Jackson S Musuuza; Michelle Schmitz; Ahmed Al-Niaimi; Nasia Safdar Journal: Am J Infect Control Date: 2016-12-09 Impact factor: 2.918
Authors: Michelle Kuznicki; Adrianne Mallen; Emily Clair McClung; Sharon E Robertson; Sarah Todd; David Boulware; Stacy Martin; Rod Quilitz; Roberto J Vargas; Sachin M Apte Journal: Int J Gynecol Cancer Date: 2020-07-29 Impact factor: 3.437
Authors: Lea A Moukarzel; Maureen E Byrne; Stephanie Leiva; Michelle Wu; Qin C Zhou; Alexia Iasonos; Nadeem R Abu-Rustum; Yukio Sonoda; Ginger Gardner; Mario M Leitao; Vance A Broach; Dennis S Chi; Kara Long Roche; Oliver Zivanovic Journal: Gynecol Oncol Date: 2020-05-24 Impact factor: 5.482
Authors: Alli M Straubhar; Jennifer L Wolf; Ms Qin C Zhou; Alexia Iasonos; Stephanie Cham; Jason D Wright; Kara Long Roche; Dennis S Chi; Oliver Zivanovic Journal: Gynecol Oncol Date: 2020-12-04 Impact factor: 5.482
Authors: Beryl L Manning-Geist; Renee A Cowan; Brooke Schlappe; Kenya Braxton; Yukio Sonoda; Kara Long Roche; Mario M Leitao; Dennis S Chi; Oliver Zivanovic; Nadeem R Abu-Rustum; Jennifer J Mueller Journal: Gynecol Oncol Rep Date: 2022-02-03
Authors: Thomas Boerner; Edward Tanner; Olga Filippova; Qin C Zhou; Alexia Iasonos; William P Tew; Roisin E O'Cearbhaill; Rachel N Grisham; Ginger J Gardner; Yukio Sonoda; Nadeem R Abu-Rustum; Oliver Zivanovic; Kara Long Roche; Anoushka M Afonso; Mary Fischer; Dennis S Chi Journal: Gynecol Oncol Date: 2020-11-17 Impact factor: 5.482